Afficher la notice abrégée

Monoclonal Antibody-Directed Therapy

dc.contributor.editorKayser, Veysel
dc.contributor.editorDatta-Mannan, Amita
dc.date.accessioned2022-02-24T10:37:05Z
dc.date.available2022-02-24T10:37:05Z
dc.date.issued2022
dc.identifierONIX_20220224_9783036528724_102
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/78804
dc.description.abstractThe book deals with therapeutic monoclonal antibodies (mAbs) broadly, and relevant topics such as challenges and opportunities, next-generation antibody products, Antibody-Drug-Conjugates (ADC), bispecifics, glycosylation, and T-cell engagers are covered. Each topic has been written by leading groups around the world and the book should be of interest to researchers from both academia and industry.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.classificationthema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industriesen_US
dc.subject.othertherapeutic antibody
dc.subject.otherstability
dc.subject.otheraggregation
dc.subject.othermanufacture challenges
dc.subject.otherformulation
dc.subject.otherantibodies
dc.subject.othersite-specific conjugation
dc.subject.otherbioconjugates
dc.subject.otherADC
dc.subject.otherantibody-drug conjugates
dc.subject.otherpayloads
dc.subject.otherlinkers
dc.subject.othernucleic acids
dc.subject.otherADME
dc.subject.otherdevelopability
dc.subject.otherglycosylation
dc.subject.otherpost-translational modifications
dc.subject.otherpharmacokinetics
dc.subject.othereffector functions
dc.subject.otherantibody-dependent cell-mediated cytotoxicity
dc.subject.othercomplement-dependent cytotoxicity
dc.subject.otherimmunogenicity
dc.subject.otherpharmacodynamics
dc.subject.otherglycoengineering
dc.subject.othertype III secretion system
dc.subject.otherprophylaxis
dc.subject.otherantibacterials
dc.subject.otherantibiotics
dc.subject.otherHIV/AIDS
dc.subject.otherco-formulation
dc.subject.otherhigh concentration
dc.subject.otheranalytical characterization
dc.subject.otherantibody (s)
dc.subject.otherT-cell engagers
dc.subject.otherbispecific antibodies
dc.subject.otherimmunotherapy
dc.subject.otheroncology
dc.subject.otherantibody engineering
dc.subject.otherimmunological synapse
dc.titleMonoclonal Antibody-Directed Therapy
dc.typebook
oapen.identifier.doi10.3390/books978-3-0365-2872-4
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0
oapen.relation.isbn9783036528724
oapen.relation.isbn9783036528731
oapen.pages142
oapen.place.publicationBasel


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/4.0/